Allison Zavitz

Allison Zavitz

Company: Roche

Job title: Lifecycle Leader, KRAS


From Conception to Accessible: Making Strategic Decisions About the Development, Adoption & Promotion of RAS-Targeted Therapies 3:01 pm

With two approved therapies (Sotorasib and Adagrasib), the field has certainly achieved the monumental task of validating RAS as a “druggable” target. However, the landscape of RAS drugs stretches from conception to phase 3 clinical trials. Making the right decisions to develop your drug before approval, and then make it accessible to patients after approval…Read more

day: Workshop F

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.